ProJenX, Inc.
Biotechnology company · Nissequogue, New York, United States
ProJenX, Inc. is a biotechnology company headquartered in Nissequogue, New York, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $5.1 million sold in a notice filed in 2022.
ProJenX at a glance
What does ProJenX do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $5.1 million sold (2022).
Frequently asked questions about ProJenX
Where is ProJenX headquartered?
ProJenX, Inc. is headquartered in Nissequogue, New York, United States.
What does ProJenX do?
ProJenX, Inc. is a biotechnology company.
When was ProJenX founded?
The earliest incorporation on record for ProJenX, Inc. is in 2021, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences